Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells.

Marta L DeDiego Yadileiny Portilla Neus Daviu Darío López-García Laura Villamayor Vladimir Mulens-Arias Jesús Garcia Ovejero Álvaro Gallo-Cordova Sabino Veintemillas María Del Puerto Morales Domingo F Barber

Published in: Journal of nanobiotechnology (2022)

Therefore, our results suggest that IONPs and IOHNPs may be repurposed to be used as prophylactic or therapeutic treatments in order to combat SARS-CoV-2 infection.

Keyphrases

iron oxide
induced apoptosis
respiratory syndrome coronavirus
cell cycle arrest
endothelial cells
endoplasmic reticulum stress
sars cov
coronavirus disease
iron deficiency
pi k akt